Literature DB >> 2929811

A new epidemiologic and laboratory classification system for paralytic poliomyelitis cases.

R W Sutter1, E W Brink, S L Cochi, O M Kew, W A Orenstein, R J Biellik, A R Hinman.   

Abstract

An epidemiologic classification of paralytic poliomyelitis cases (ECPPC) has been in use in the United States since 1976. In 1985, this classification system was reviewed because of recent changes in the epidemiology of paralytic poliomyelitis and improved laboratory capability to definitively characterize poliovirus strains. An alternative classification system was devised, the epidemiologic and laboratory classification of paralytic polio cases (ELCPPC), that incorporated virus isolation and strain characterization with epidemiologic information. Reported paralytic poliomyelitis cases for 1980-86 were classified by both the ECPPC and the ELCPPC classification systems. The new ELCPPC system classified 91 per cent of the reported cases as vaccine-associated, while the ECPPC system classified only 71 per cent of the reported cases as vaccine-associated. The proposed classification system provides more specific and useful information particularly concerning vaccine-associated paralytic poliomyelitis.

Entities:  

Mesh:

Year:  1989        PMID: 2929811      PMCID: PMC1349984          DOI: 10.2105/ajph.79.4.495

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  12 in total

1.  Parameters for differentiating vaccine-derived and wild poliovirus strains.

Authors:  J H Nakano; M H Hatch; M L Thieme; B Nottay
Journal:  Prog Med Virol       Date:  1978

2.  Geographic distribution of wild poliovirus type 1 genotypes.

Authors:  R Rico-Hesse; M A Pallansch; B K Nottay; O M Kew
Journal:  Virology       Date:  1987-10       Impact factor: 3.616

3.  The case for global eradication of poliomyelitis.

Authors:  A R Hinman; W H Foege; C A de Quadros; P A Patriarca; W A Orenstein; E W Brink
Journal:  Bull World Health Organ       Date:  1987       Impact factor: 9.408

4.  Genetic and antigenic variation in type 3 polioviruses: characterization of strains by monoclonal antibodies and T1 oligonucleotide mapping.

Authors:  P D Minor; G C Schild; M Ferguson; A Mackay; D I Magrath; A John; J P Yates; M Spitz
Journal:  J Gen Virol       Date:  1982-08       Impact factor: 3.891

5.  Monoclonal antibodies of four different specificities for neutralization of type 1 polioviruses.

Authors:  D D Humphrey; O M Kew; P M Feorino
Journal:  Infect Immun       Date:  1982-05       Impact factor: 3.441

6.  Monoclonal antibodies to polioviruses. Comparison of intratypic strain differentiation of poliovirus type 1 using monoclonal antibodies versus cross-absorbed antisera.

Authors:  A D Osterhaus; A L van Wezel; T G Hazendonk; F G UytdeHaag; J A van Asten; B van Steenis
Journal:  Intervirology       Date:  1983       Impact factor: 1.763

7.  Eradication of poliomyelitis in the United States.

Authors:  N Nathanson
Journal:  Rev Infect Dis       Date:  1982 Sep-Oct

8.  Natural variation of poliovirus neutralization epitopes.

Authors:  R Crainic; P Couillin; B Blondel; N Cabau; A Boué; F Horodniceanu
Journal:  Infect Immun       Date:  1983-09       Impact factor: 3.441

9.  Poliomyelitis in the USA: virtual elimination of disease caused by wild virus.

Authors:  R J Kim-Farley; K J Bart; L B Schonberger; W A Orenstein; B M Nkowane; A R Hinman; O M Kew; M H Hatch; J E Kaplan
Journal:  Lancet       Date:  1984-12-08       Impact factor: 79.321

10.  Vaccine-associated poliomyelitis in the United States, 1961-1972.

Authors:  L B Schonberger; J E McGowan; M B Gregg
Journal:  Am J Epidemiol       Date:  1976-08       Impact factor: 4.897

View more
  4 in total

1.  Evolution of the Sabin type 1 poliovirus in humans: characterization of strains isolated from patients with vaccine-associated paralytic poliomyelitis.

Authors:  M M Georgescu; J Balanant; A Macadam; D Otelea; M Combiescu; A A Combiescu; R Crainic; F Delpeyroux
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

2.  Fifty Years of Global Immunization at CDC, 1966-2015.

Authors:  Eric E Mast; Stephen L Cochi; Olen M Kew; K Lisa Cairns; Peter B Bloland; Rebecca Martin
Journal:  Public Health Rep       Date:  2016-12-19       Impact factor: 2.792

3.  High diversity of poliovirus strains isolated from the central nervous system from patients with vaccine-associated paralytic poliomyelitis.

Authors:  M M Georgescu; F Delpeyroux; M Tardy-Panit; J Balanant; M Combiescu; A A Combiescu; S Guillot; R Crainic
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

4.  Application of monoclonal antibody panels in the virological and epidemiological review of poliomyelitis in Poland, 1981-1990.

Authors:  Z Jarzabek; J Zabicka; A John; J Howlett; G Dunn; D J Wood
Journal:  Bull World Health Organ       Date:  1992       Impact factor: 9.408

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.